Objectives-To evaluate a spectrophotometric field kit (Test-Mate-OP) for repeatability and validity in comparison with reference laboratory methods and to model its anticipated sensitivity and specificity based on these findings.
Methods-76 farm workers between the age of 20 and 55, of whom 30 were pesticide applicators exposed to a range of organophosphates in the preceding 10 days, had blood taken for plasma cholinesterase (PCE) and erythrocyte cholinesterase (ECE) measurement by field kit or laboratory methods. Paired blinded duplicate samples were taken from subgroups in the sample to assess repeatability of laboratory and field kit methods. Field kits were also used to test venous blood in one subgroup. The variance obtained for the field kit tests was then applied to two hypothetical scenarios that used published action guidelines to model the kit's sensitivity and specificity. Results-Repeatability for PCE was much poorer and for ECE slightly poorer than that of laboratory measures. A substantial upward bias for field kit ECE relative to laboratory measurements was found. Sensitivity of the kit to a 40% drop in PCE was 67%, whereas that for ECE was 89%. Specificity of the kit with no change in mean of the population was 100% for ECE and 91% for PCE. Conclusion-Field kit ECE estimation seems to be sufficiently repeatable for surveillance activities, whereas PCE does not. Repeatability of both tests seems to be too low for use in epidemiological dose-response investigations. Further research is indicated to characterise the upward bias in ECE estimation on the kit.
(Occup Environ Med 1995;52:57-64) Keywords: cholinesterase; field kit; repeatability Agrichemicals are extensively used in farming and public health programmes worldwide and their potential for adverse health effects is considerable.' 2 Biological monitoring of humans potentially exposed to agrichemicals has been widely recommended for the prevention of pesticide poisoning 4 and for purposes of epidemiological research. 5 Proposed changes to South African occupational health legislation6 are likely to make medical monitoring of workers exposed to potentially hazardous chemicals mandatory and thus bring statutory requirements into line with international standards. 4 Given that farm workers will fall under the ambit of the new legislation,6 attention is likely to be directed at identifying cheap and practical methods that are both reliable and valid for field monitoring of workers exposed to agrichemicals.
Organophosphates and carbamates constitute the most widely used insecticides in South Africa at present,89 and measurement of serum and red blood cell cholinesterase is widely used to monitor exposed people.' 3 4 10 1l Decreased plasma cholinesterase (PCE) activity is regarded as a marker of recent exposure, and in erythrocytes (ECE) of neuronal toxicity.3 The magnitude of cholinesterase depression is also used as an action guide for removal of a worker from further exposure. 4 Laboratory methods for estimating cholinesterase activity have been well described." 12 For public health purposes, however, Once again, the repeatability of the laboratory measurements is far better than that of both the field and non-field application of the kit. In this case, the repeatability of the nonfield kit is worse than that of the field kit, but this is based on a small sample (n = 14). The repeatability coefficient of the field kit ECE, implicit in table 1 as the upper limit of agreement less the mean difference, is 2-4 times that of the laboratory. Although the field kit ECE still performed worse than the laboratory, this represents an improvement in quality when compared with the PCE repeatability.
VALIDITY PCE determinations Figure 4 shows a plot of the difference between kit (under field conditions) and laboratory PCE measurements v their average, group -500
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Mean of kit and lab PCE Table 3 shows the estimates of probabilities of false positives and false negatives calculated from the variances estimated from repeat readings in our sample with an assumed 30% drop in baseline cholinesterase as a threshold for action. For PCE a 30% drop in activities from the observed field kit average of 3091-2 U/l would be 927-4 U/l and for ECE (average 45-1 U/g) would be 13-5 U/g. The kit would miss a true drop in PCE of 40% from baseline in 33% of cases, and a 40% drop in ECE in 11%. A full exposition of the method of calculation is contained in the appendix. and graphically illustrates the mean difference and the limits of agreement. Again, a wide scatter is evident, with a slight downward bias of kit relative to laboratory. This is confirmed in table 2, which summarises data on the difference between laboratory, field, and nonfield kit PCE measurements and provides estimates of correlation, bias, and upper and lower limits of agreement.
The downward bias of the kit measurements relative to the laboratory measurements is not substantial relative to the activity of PCE. For example, the mean difference between field kit and laboratory measures is of the order of 6% of mean laboratory PCE in table 1, and for non-field use of the kit the 95% CI of the differences includes 0. In absolute terms, field kit PCE may be from 1370-3 U/l below to 935-6 U/l above the laboratory readings for the same subject. The nonfield kit application performs better than the field kit in terms of bias, but they are of comparable variability relative to the laboratory measurements. Table 2 shows analogous estimates of correlation, bias, and upper and lower limits of agreement for ECE measurements that compare laboratory methods with field and nonfield kit determinations. The kit is biased upwards and, in contrast to PCE, the extent of the bias relative to the laboratory ECE activities is substantial. Field kit ECE may be 1-3 U/g haemoglobin below to 17-7 U/g haemoglobin above the laboratory readings and the mean difference between kit and laboratory measures is of the order of 23% of mean laboratory ECE. The variability of the field and non-field application of the kit relative to the laboratory is comparable. Even when venous blood was used as the source for kit estimations (non-field conditions), which may be expected to obviate many of the field obstacles to optimal test performance, (including haemoconcentration in successive drops of finger prick blood), the repeatability of the kit PCE determinations improved somewhat, but remained substantially worse than that of the laboratory. It must also be borne in mind that the kit is intended for use in field conditions and that this is where its usefulness most needs to be evaluated.
ECE determinations
The validity assessment in this study suggested that relative to the laboratory, the field kit readings of PCE were systematically low, and that there was also a more substantial upward bias relative to the laboratory in the kit ECE readings. In the examination of plots of difference against the mean2' no evidence was present that the Clearly, the kit and laboratory results for ECE were not comparable. One explanation for the results may lie in the different manner in which interference by PCE in the measurement of ECE is prevented. In the laboratory, this is accomplished by physical separation of plasma and erythrocytes, whereas the kit relies on As1397 to inhibit PCE in whole blood. Incomplete inhibition of the PCE in the field kit may be responsible for the overestimation of ECE. Another explanation may be the presence of residual acetylcholinesterase activity in serum,25 reported to be of the order of 10%.26 If either of these factors are constant across a range of ECE activities, as suggested by our data, it may be possible to adjust for this overestimation by applying a conversion factor, and further research is needed to clarify this possibility.
A different approach to validity is to establish normal ranges for the field kit based on appropriate reference populations. However, data on this has yet to be reported in the scientific literature, and the difficulties of locating an appropriate control group, particularly in South Africa, are considerable. High levels of alcohol consumption, chronic liver disease, malnutrition, and anaemia are known determinants of PCE and ECE activities3 and are factors that are prevalent among both farm workers and non-farm worker populations in South Africa. Also, the possibility of environmental contamination due to agrichemicals in rural areas would further complicate the use of rural control subjects to establish normal ranges.
A preferred method of estimation of cholinesterase to identify affected workers is to use subjects as their own controls in prospective measurements over a season, and this is recommended in the field kit manual."8
The comparison of a cholinesterase result with a subject's baseline value before exposure is the object of biological monitoring in the workplace to enable prompt preventive action to be taken. California regulations rely on a decrease from baseline activities of 30% of either PCE or ECE to warrant further action (repeat test) and of 40% in ECE and 50% in PCE to spur removal from exposure.3
Based on the repeatability found in this study, and with the observed baselines (table 3), the kit seems to miss a true drop in PCE of 40% from baseline in 33% of cases. The equivalent probability for a 40% drop in ECE is 11%, which is more satisfactory. The poor performance of the kit PCE may be partly due to exposed study subjects who have PCE activities already lower than normal. From the same calculations as in the appendix, but with higher baselines for PCE-that is, 4000 and 6000-the frequency of false negatives drops to 29% and 20% respectively, but still remains unacceptably high.
Moreover, these results reflect an optimistic assessment as they are based on measurements taken at a single point in time. Greater variability would be introduced with additional measurements at different points in time, which would therefore decrease the likelihood of detecting real changes in cholinesterase activities. Follow up data are presently being analysed to illucidate the effects of this added variability on the ability of the kit to detect changes in PCE and ECE over time.
High levels of instrument variability also compromise the usefulness of the kit in epidemiological studies to investigate dose response relations. This is exacerbated where within and between individual variation in the measured variable may be high, as has been reported for cholinesterase activity.3 Estimates of maximum variation in PCE activity of healthy subjects are of the order of 9%3 to 14%,27 whereas that for between person variability may be substantially higher.328 If a measurement device itself has poor repeatability, the chances of non-differential misclassification are greatly enhanced, and the value of the field kit with a repeatability coefficient as high as shown by our data, may render {he kit of limited value for detecting exposure-outcome effects. This served as an important motivation for a decision to rely on laboratory measures of cholinesterase in our larger study of chronic neurotoxic effects.
An issue not assessed in this study is the effect of different readers on kit repeatability and validity as all kit measurements were performed by a single observer (MB). Given that one researcher performed all the kit tests in a standardized manner, we think that noninstrument human error was kept to a minimum in this study. This is consistent with our experience in piloting the device in 1992 where a different reader (LL) found a similar upward bias in kit ECE and poorer repeatability for both kit ECE and PCE relative to the laboratory, although the levels of variability of the methods differed from those of the current study.
An additional reason for the use of field monitoring devices may be economic. In our experience, however, in a developing country, the costs of the field kit tests are not insubstantial when compared with those of laboratory tests. For example, laboratory costs for PCE and ECE assays are about $4 and $5-20 respectively, whereas the costs of purchasing the kit and reagents for the first 200 PCE and ECE assays were of a similar order ($5). With increasing numbers of tests, the average costs for the field kit decrease because of economy of scale. Unless the kit is to be used for a large number of tests, this cost saving will not be substantial.
Conclusion
Despite the undoubted value of a field instrument, to be used on farms to obtain immediate cholinesterase results with minimal reader training, limitations are apparent in the performance of the field kit for cholinesterase measurement relative to laboratory measurements. These include the presence of an upward bias of ECE as measured on the kit jRepeatability and validity of a field kitfor estimation of cholinesterase in whole blood relative to the laboratory, and more importantly, poor kit repeatability relative to laboratory measurements, particularly for PCE.
These shortcomings seriously detract from the potential usefulness of the kit for epidemiological studies to investigate dose response relations, and for surveillance purposes. Because the ECE repeatability of the field kit is somewhat better than PCE, the estimation of ECE by the field kit may be sufficient for purposes of biological monitoring with the use of a model based on California regulations. The ease and simplicity of use of the kit needs to be balanced against its lack of repeatability in the field.
Several issues for future research into the kit have been raised in this study. These include the characterization of the constancy of the upward bias in ECE estimation and the reasons for this bias, the elaboration of the sources of variation that contributed to poor repeatability of the kit results, and field research into the impact of less than ideal field conditions on kit performance, which is especially important for its use in developing countries where field methods are most needed. The threshold for action with regard to a person is a drop in cholinesterase to below 70% of the baseline measure. Thus if X2 < 0-7 X, then further action is indicated.
False positives occur if: X, < 0 7 X, but, in fact, udi,, = 0.
False negatives occur if:
X2 > 0-7 X, but, in fact, Ydiff = c, where c > 0,3 p,.
To be able to estimate the sensitivity and specificity of this action threshold, we use the sample values of the various model parameters. Specifically, we assume for PCE that: It must be kept in mind, however, that ,,,ff2 and cov(X,, X2) are not based on repeat measurements separated by a period of time-for example: before and after the season, and so we are almost certainly underestimating the variability and hence giving too optimistic an assessment of the usefulness of the field kit in this context. The probability of action being signalled is then given by: P(X, < 0 7X,) or P(0 7X, -X2 > 0). Now 0-7X, -X2 -N(diff 0310 3,, adiff 0-51 a 2+ 06 cov(X, X2))-Under the null hypothesis that PM,,, = 0, we have that: P(X2 < 0-7X,) = 1 -P(ZN(O,I, < 1-34) = 0 09.
Thus we estimate that if there is no change in mean PCE activity, 9% of workers will be falsely diagnosed as having PCE activities that have fallen below the threshold. This means that the specificity of this PCE action procedure, when applied through the field kit, is 91%. It must be kept in mind that this may be an optimistic assessment.
We consider further the proportion of subjects who would not be detected by this action procedure in the situation where the true mean PCE activities have dropped by 40%. Under the alternative hypothesis that Pdcf = 0 4 A,, we have: P(X2 > 07X,) = P(ZNO < 0 45) = 0 33.
Thus if the true mean PCE activity of the subjects has, in fact, dropped by 40%, 33% of such subjects will not be detected by this action threshold. This means that the sensitivity of the PCE action procedure (in the presence of a 40% drop in PCE activity) is 67%.
The 
